Jane Street’s Immunocore IMCR Stock Holding History

Jane Street’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.78M	Buy	59,200 +37,500	+173%	+$1.21M	﹤0.01%	5316
2025 Q4	$753K	Buy	+21,700	New	+$766K	﹤0.01%	6775
2025 Q1	–	Sell	-11,400	Closed	-$336K	–	9967
2024 Q4	$336K	Sell	11,400 -46,400	-80%	-$1.47M	﹤0.01%	7547
2024 Q3	$1.8M	Sell	57,800 -54,400	-48%	-$1.98M	﹤0.01%	4704
2024 Q2	$3.8M	Sell	112,200 -57,000	-34%	-$2.91M	﹤0.01%	3405
2024 Q1	$11M	Buy	169,200 +88,500	+110%	+$6.07M	﹤0.01%	1727
2023 Q4	$5.51M	Buy	80,700 +56,200	+229%	+$2.92M	﹤0.01%	2714
2023 Q3	$1.27M	Sell	24,500 -86,000	-78%	-$5.09M	﹤0.01%	4797
2023 Q2	$6.63M	Buy	110,500 +700	+0.6%	+$40K	﹤0.01%	2373
2023 Q1	$5.43M	Buy	+109,800	New	+$6.17M	﹤0.01%	2334

Other funds holding IMCR

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

VPC

Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Jane Street's IMCR Position: Q1 2026 in Review

Jane Street increased its Immunocore (IMCR) stake by 102% in Q1 2026, buying an estimated $3.35M and bringing the position to 204,368 shares worth $6.16M. The position accounts for ﹤0.01% of the portfolio, ranked #3207.

Jane Street first reported a position in IMCR in Q2 2022 and has held it in 14 quarters since. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

Jane Street held 204,368 shares of Immunocore worth $6.16M as of Q1 2026.
Jane Street bought 103,428 Immunocore shares in Q1 2026, an estimated $3.35M.
Immunocore made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #3207 holding.
Jane Street first reported a position in Immunocore in Q2 2022 and has held it in 14 quarters since.
142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.